New advances in microsphere-based single-dose vaccines

被引:141
作者
Hanes, J
Cleland, JL
Langer, R
机构
[1] JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSURG,BALTIMORE,MD 21205
[2] GENENTECH INC,PHARMACEUT R&D,S SAN FRANCISCO,CA 94080
[3] MIT,DEPT CHEM ENGN,CAMBRIDGE,MA 02139
关键词
biodegradable microspheres; antigen delivery; vaccine delivery; antigen stability; immunization; controlled release; microsphere preparation; mucosal immunization; vaccine adjuvants;
D O I
10.1016/S0169-409X(97)00053-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Polymer microspheres have shown great potential as a next generation adjuvant to replace or complement existing aluminum salts for vaccine potentiation. Microsphere-based systems can now be made to deliver subunit protein and peptide antigens in their native form in a continuous or pulsatile fashion for periods of weeks to months with reliable and reproducible kinetics, often obviating the need for booster immunizations in animal models. Microspheres have also shown potential as carriers for oral vaccine delivery due to their protective effects on encapsulated antigens and their ability to be taken up by the Peyer's patches in the intestine. The potency of these optimal depot formulations for antigen may be enhanced by the co-delivery of vaccine adjuvants, including cytokines, that are either entrapped in the polymer matrix or, alternatively, incorporated into the backbone of the polymer itself and released concomitantly with antigen as the polymer degrades. In this article we review the use of polymer microspheres for single-step immunization and discuss future applications for the improvement of vaccines and immunotherapies by utilizing encapsulation technology. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:97 / 119
页数:23
相关论文
共 153 条
[1]   STRATEGIES FOR EXPLOITING THE IMMUNE-SYSTEM IN THE DESIGN OF VACCINES [J].
ADA, G .
MOLECULAR IMMUNOLOGY, 1991, 28 (03) :225-230
[2]   CONTROLLED-RELEASE VACCINES - BIODEGRADABLE POLYLACTIDE POLYGLYCOLIDE (PL/PG) MICROSPHERES AS ANTIGEN VEHICLES [J].
AGUADO, MT ;
LAMBERT, PH .
IMMUNOBIOLOGY, 1992, 184 (2-3) :113-125
[4]   BIODEGRADABLE MICROSPHERES AS CONTROLLED-RELEASE TETANUS TOXOID DELIVERY SYSTEMS [J].
ALONSO, MJ ;
GUPTA, RK ;
MIN, C ;
SIBER, GR ;
LANGER, R .
VACCINE, 1994, 12 (04) :299-306
[5]   DETERMINANTS OF RELEASE RATE OF TETANUS VACCINE FROM POLYESTER MICROSPHERES [J].
ALONSO, MJ ;
COHEN, S ;
PARK, TG ;
GUPTA, RK ;
SIBER, GR ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1993, 10 (07) :945-953
[6]   DELIVERY OF LIPOSOME-ENCAPSULATED DRUGS TO MACROPHAGES [J].
ALVING, CR .
PHARMACOLOGY & THERAPEUTICS, 1983, 22 (03) :407-424
[7]  
[Anonymous], 1994, NOVEL DELIVERY SYSTE
[8]   FACTORS AFFECTING SHORT-TERM AND LONG-TERM STABILITIES OF PROTEINS [J].
ARAKAWA, T ;
PRESTRELSKI, SJ ;
KENNEY, WC ;
CARPENTER, JF .
ADVANCED DRUG DELIVERY REVIEWS, 1993, 10 (01) :1-28
[9]   HUMAN IMMUNIZATION IN DEVELOPING-COUNTRIES - PRACTICAL AND THEORETICAL PROBLEMS AND PROSPECTS [J].
ARYA, SC .
VACCINE, 1994, 12 (15) :1423-1435
[10]   SUBCUTICULAR SUTURES AND THE RATE OF INFLAMMATION IN NONCONTAMINATED WOUNDS [J].
AUSTIN, PE ;
DUNN, KA ;
EILYCOFIELD, K ;
BROWN, CK ;
WOODEN, WA ;
BRADFIELD, JF .
ANNALS OF EMERGENCY MEDICINE, 1995, 25 (03) :328-330